Clinical trials
Carcinoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 7 |
| 2012 | 2 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 9 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Active, not recruiting | 13 |
| Recruiting | 12 |
| Terminated | 11 |
| Unknown status | 3 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 9 |
| Novartis Pharmaceuticals | 6 |
| Pfizer | 4 |
| Eli Lilly and Company | 3 |
| Merck Sharp & Dohme LLC | 3 |
| University Health Network, Toronto | 3 |
| AHS Cancer Control Alberta | 2 |
| Blueprint Medicines Corporation | 2 |
| Daiichi Sankyo | 2 |
| Exelixis | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 80 |
| Neoplasms | 28 |
| Carcinoma, Non-Small-Cell Lung | 26 |
| Lung Neoplasms | 18 |
| Neoplasm Metastasis | 11 |
| Adenocarcinoma | 10 |
| Neoplasms by Site | 10 |
| Lung Diseases | 8 |
| Bronchial Neoplasms | 6 |
| Colorectal Neoplasms | 6 |
Trials
Showing 51 to 75 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.